Primary and secondary prevention in stroke: Approact to diabetes mellitus cases

Basit Öğe Kaydı
dc.authorscopusid16246835900
dc.authorscopusid8944423400
dc.contributor.authorUludüz, Derya
dc.contributor.authorDuman, Taşkin
dc.date.accessioned2024-09-19T15:47:02Z
dc.date.available2024-09-19T15:47:02Z
dc.date.issued2014
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractMicroangiopathy and macroangiopathy are induced by increased the tendency of atherosclerosis caused by metabolic impairment. The prerevalance of diabetes mellitus is 15-33% in cases with ischemic stroke. Diabetes mellitus is an independent risk factor especially for stroke and it can increase the relative risk (RR) 1.8-6 times for initial stroke. The risk of ischemic stroke is higher in women with diabetes. Individual adjustment of glycemic targets is performed but treatment regulation as to set ? 7.0% of HbA1C is recommended for decreasing the microvascular and macrovascular complications if the history of stroke or TIA are present. The targeted fasting plasma glucose levels should be ranged from 4.0 to 7.0 mmol/L and the targeted plasma glucose levels at postprandial second hour should be ranged from 5.0 to 10.0 mmol/L. Daily physial activity, weight control, blood pressure control, lipid control and life style changes are recommended to all diabetic patients. Also, medical treatment is commonly needed for targeted HbA1C levels. In diabetic patients, Metformin is an effective first-line pharmacotherapy to decrease the stroke risk. Also, monotherapy with fibrates can be considered. It is proposed to set the blood preassure at < 130/80 mmHg with ACEI or ARB hypertension treatments in diabetic patients. Diabetic adults with additionally risk factors should be treated with statins to decrease the risk of initial stroke. The benefit of antiagregant usage to decrease the stroke risk is not clear yet, however aspirin usage can suitable in diabetic patients with increased cardiovascular event risk.en_US
dc.identifier.doi10.5505/tbdhd.2014.83803
dc.identifier.endpage6en_US
dc.identifier.issn1301-1375
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-84898478093en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage1en_US
dc.identifier.urihttps://doi.org/10.5505/tbdhd.2014.83803
dc.identifier.urihttps://hdl.handle.net/20.500.12483/14923
dc.identifier.volume20en_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.publisherTurkish Society of Cerebrovascular Diseasesen_US
dc.relation.ispartofTurk Beyin Damar Hastaliklar Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectDiabetes mellitusen_US
dc.subjectPrimary preventionen_US
dc.subjectSecondary preventionen_US
dc.subjectStrokeen_US
dc.titlePrimary and secondary prevention in stroke: Approact to diabetes mellitus casesen_US
dc.title.alternativeİnmede ?i?ri?ncil ?v?e ?ikincil koru?nma: Diabe?es mellitus olgulari?na yaklasimen_US
dc.typeReview Articleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu